Wednesday, July 26, 2023 11:41:37 AM
But, one type of insolvency proceeding is a restructuring, which may include a merger.
https://www.chamberlain-co.co.uk/stages-of-insolvency/
I think this is clearly the path we are on. In evidence of that was our purchase of 500K shares of Baudax Bio on June 30th, which was when Baudax acquired TeraImmune. And TeraImmune also focuses on suppressing immune response, while Baudax has a small CDMO it is associated with. Good framework to build upon.
And no one has mentioned that Humanigen could very well own every share they have issued, which I think they do. I think we are poised to initiate a forward stock split with our merger, and cause a short squeeze.
As you noted, the company is "...exploring all restructuring options..." Why would we have funded Baudax's acquisition of TeraImmune, if we did not plan to merge with them?
Just my opinion, with just enough subtle substantiation for me to comfortably make that conclusion.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM